Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Keratosis, Actinic × Melatonin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Sleep Wake Disorders 1 Sleep Disorders, Circadian Rhythm 1 Radiodermatitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Neoplasms 1 Neoplasm Metastasis 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Depression 1 Delirium 1 Brain Neoplasms 1 Brain Concussion 1

Interventions

Aminolevulinic Acid 11 3-ingenyl angelate 9 Photochemotherapy 5 Imiquimod 5 Fluorouracil 4 Petrolatum 3 Solutions 2 SR-T100 2 Gels 2 Cryotherapy 2 potassium dobesilate 1 perillyl alcohol 1 endonuclease V, phage T4 1 dehydroftorafur 1 calcipotriene 1 afamelanotide 1 Triamcinolone 1 Therapies, Investigational 1 Papillomavirus Vaccines 1 Ointments 1 Melatonin 1 LEO 43204 1 Isotretinoin 1 Imipramine 1 Excipients 1 Eflornithine 1 Deoxyribonuclease (Pyrimidine Dimer) 1 Cholecalciferol 1 Chemexfoliation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05740969 2023-02-23

PACKS

Zealand University Hospital

Phase 2 Unknown

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡